Aller au contenu principal

 Articles scientifiques

Lessons learned at SABCS 2019 and to-dos from immunotherapy in breast cancer.

Auteurs : Eiger D, Brandão M, de Azambuja E
Année : 2020
Journal : ESMO Open
Volume : 5

Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis.

Auteurs : de Azambuja E, Brandão M, Wildiers H, Laenen A, Aspeslagh S, Fontaine C, Collignon J, Lybaert W, Verheezen J, Rutten A, Vuylsteke P, Goeminne JC, Demey W, Van Beckhoven D, Deblonde J, Rottey S, Geukens T, Punie K
Année : 2020
Journal : ESMO Open
Volume : 5

Breast cancer subtypes: implications for the treatment and survival of patients in Africa-a prospective cohort study from Mozambique.

Auteurs : Brandão M, Guisseve A, Bata G, Alberto M, Ferro J, Garcia C, Zaqueu C, Lorenzoni C, Leitão D, Come J, Soares O, Gudo-Morais A, Schmitt F, Tulsidás S, Carrilho C, Lunet N
Année : 2020
Journal : ESMO Open
Volume : 5

Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis.

Auteurs : Brandão M, Maurer C, Ziegelmann PK, Pondé NF, Ferreira A, Martel S, Piccart-Gebhart M, de Azambuja E, Debiasi M, Lambertini M
Année : 2020
Journal : ESMO Open
Volume : 5

Cardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trials.

Auteurs : Eiger D, Franzoi MA, Pondé N, Brandão M, de Angelis C, Schmitt Nogueira M, de Hemptinne Q, de Azambuja E
Année : 2020
Journal : ESMO Open
Volume : 5

What Is the Real Impact of Estrogen Receptor Status on the Prognosis and Treatment of HER2-Positive Early Breast Cancer?

Auteurs : Brandão M, Caparica R, Malorni L, Prat A, Carey LA, Piccart-Gebhart M
Année : 2020
Journal : Clin Cancer Res
Volume : 26
Pages : 2783-2788

Treatment and Other Healthcare Use of Breast Cancer Patients With a Previous Cancer Diagnosis.

Auteurs : Morais S, Costa AR, Lopes-Conceicao L, Brandão M, Borges M, Araujo N, Dias T, Fontes F, Pereira S, Lunet N
Année : 2020
Journal : Anticancer Res
Volume : 40
Pages : 1041-1048

Healthcare use and costs in early breast cancer: a patient-level data analysis according to stage and breast cancer subtype.

Auteurs : Brandão M, Morais S, Lopes-Conceição L, Fontes F, Araújo N, Dias T, Pereira D, Borges M, Pereira S, Lunet N
Année : 2020
Journal : ESMO Open
Volume : 5

Neoadjuvant treatment for intermediate/high-risk HER2-positive and triple-negative breast cancers: no longer an 'option' but an ethical obligation.

Auteurs : Brandão M, Reyal F, Hamy AS, Piccart-Gebhart M
Année : 2019
Journal : ESMO Open
Volume : 4
Pages : e000515

Denosumab in early-stage breast cancer.

Auteurs : Brandão M, Debiasi M, de Azambuja E
Année : 2019
Journal : Lancet Oncol
Volume : 20
Pages : e234-e235

Mammaprint™: a comprehensive review.

Auteurs : Brandão M, Pondé N, Piccart-Gebhart M
Année : 2019
Journal : Future Oncol
Volume : 15
Pages : 207-224

Patient-reported outcomes and genomic signatures: tools to tailor adjuvant endocrine treatment?

Auteurs : Brandão M, Coens C, Ignatiadis M
Année : 2019
Journal : Ann Oncol
Volume : 30
Pages : 1677-1681

Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors.

Auteurs : Brandão M, Caparica R, Eiger D, de Azambuja E
Année : 2019
Journal : Ann Oncol
Volume : 30 Suppl 10
Pages : x27-x42

Systemic treatment of patients with early breast cancer: recent updates and state of the art.

Auteurs : Caparica R, Brandão M, Piccart-Gebhart M
Année : 2019
Journal : Breast
Volume : 48 Suppl 1
Pages : S7-S20

Evaluation of The Medical Board Exam in Portugal.

Auteurs : Marques TR, Laíns I, Martins MJ, Goiana-da-Silva F, Sampaio F, Pessanha I, Fernandes DH, Brandão M, Pinto Teixeira P, Oliveira Santos M, Silva JC, Ribeiro JC
Année : 2018
Journal : Acta Med Port
Volume : 31
Pages : 670-679

Treatment of advanced HER2-positive breast cancer: 2018 and beyond.

Auteurs : Pondé N, Brandão M, El-Hachem G, Werbrouck E, Piccart-Gebhart M
Année : 2018
Journal : Cancer Treat Rev
Volume : 67
Pages : 10-20

Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects.

Auteurs : Brandão M, Pondé NF, Poggio F, Kotecki N, Salis M, Lambertini M, de Azambuja E
Année : 2018
Journal : Expert Rev Anticancer Ther
Volume : 18
Pages : 629-649

Marjolin's Ulcer with Axillary Lymph Node Metastasis.

Auteurs : Fernandes MG, Brandão M, Dias EM
Année : 2018
Journal : Acta Med Port
Volume : 31
Pages : 515

CDK4/6 inhibitors as neoadjuvant treatment in breast cancer - what can we learn?

Auteurs : Brandão M, Ignatiadis M
Année : 2018
Journal : Ann Oncol
Volume : 29(12)
Pages : 2274-2278